SCHEMBL6205455

SCHEMBL6205455

CCOc1cccc([CH]COCOC)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.48
ALDH1A1 P00352 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
TP53 P04637 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP1A2 P05177 1/20 0.42
CYP2D6 P10635 1/20 0.42
MAPK1 P28482 1/20 0.42
CYP2C19 P33261 1/20 0.42
NPC1 O15118 2/20 0.40
RAB9A P51151 2/20 0.40
TDP1 Q9NUW8 1/20 0.40
RELA Q04206 1/20 0.39
ESR1 P03372 2/20 0.39
AHR P35869 1/20 0.39
MAOA P21397 4/20 0.38
MAOB P27338 4/20 0.38
CYP19A1 P11511 2/20 0.36
CYP11B1 P15538 2/20 0.36
CYP11B2 P19099 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6205403 0.86 CHRM5 (0.50) CYP3A4CYP1A2NPC1RAB9ATDP1
SCHEMBL7321393 0.77 KDM4E (0.55) KDM4EALDH1A1SMN1; SMN2TP53CYP3A4
SCHEMBL6204838 0.76 ALDH1A1 (0.47) KDM4EALDH1A1SMN1; SMN2MAPK1TDP1
SCHEMBL6204213 0.76 RELA (0.45) TP53CYP1A2CYP2D6CYP2C19RELA
SCHEMBL493931 0.75 MAOA (0.62) KDM4EALDH1A1SMN1; SMN2TP53CYP3A4
SCHEMBL29432706 0.75 MAOA (0.62) KDM4EALDH1A1SMN1; SMN2TP53CYP3A4
SCHEMBL5247739 0.75 KDM4E (0.60) KDM4EALDH1A1SMN1; SMN2TP53CYP3A4
SCHEMBL10071508 0.74 TDP1 (0.41) KDM4EALDH1A1SMN1; SMN2TP53CYP3A4
SCHEMBL10071525 0.74 TDP1 (0.41) KDM4EALDH1A1SMN1; SMN2TP53CYP3A4
Benzene SCHEMBL27795602 0.74 MAOA (0.65) KDM4EALDH1A1SMN1; SMN2TP53CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1506175-A1 N-SUBSTITUTED TRICYCLIC 3-AMINOPYRAZOLES AS PDGF RECEPTOR INHIBITORS JANSSEN PHARMACEUTICA N.V. (BE) 2005-02-16 EP disclosed
WO-2003097609-A1 N-SUBSTITUTED TRICYCLIC 3-AMINOPYRAZOLES AS PDFG RECEPTOR INHIBITORS JANSSEN PHARMACEUTICA N.V. (BE) 2003-11-27 WO disclosed